These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

154 related articles for article (PubMed ID: 26979150)

  • 1. Genomics in CKD: Is This the Path Forward?
    Nadkarni GN; Horowitz CR
    Adv Chronic Kidney Dis; 2016 Mar; 23(2):120-4. PubMed ID: 26979150
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Addressing the global burden of chronic kidney disease through clinical and translational research.
    Ojo A
    Trans Am Clin Climatol Assoc; 2014; 125():229-43; discussion 243-6. PubMed ID: 25125737
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Health disparities in kidney disease--emerging data from the human genome.
    Williams WW; Pollak MR
    N Engl J Med; 2013 Dec; 369(23):2260-1. PubMed ID: 24206461
    [No Abstract]   [Full Text] [Related]  

  • 4. APOL1 and progression of nondiabetic nephropathy.
    Palmer ND; Freedman BI
    J Am Soc Nephrol; 2013 Sep; 24(9):1344-6. PubMed ID: 23813212
    [No Abstract]   [Full Text] [Related]  

  • 5. Intensive blood-pressure control in hypertensive chronic kidney disease.
    Freedman BI; Sedor JR
    N Engl J Med; 2010 Dec; 363(26):2565; author reply 2565-6. PubMed ID: 21175324
    [No Abstract]   [Full Text] [Related]  

  • 6. Genetics of kidney failure and the evolving story of APOL1.
    Friedman DJ; Pollak MR
    J Clin Invest; 2011 Sep; 121(9):3367-74. PubMed ID: 21881214
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The evolving science of apolipoprotein-L1 and kidney disease.
    Chen TK; Estrella MM; Parekh RS
    Curr Opin Nephrol Hypertens; 2016 May; 25(3):217-25. PubMed ID: 27023839
    [TBL] [Abstract][Full Text] [Related]  

  • 8. High population frequencies of APOL1 risk variants are associated with increased prevalence of non-diabetic chronic kidney disease in the Igbo people from south-eastern Nigeria.
    Ulasi II; Tzur S; Wasser WG; Shemer R; Kruzel E; Feigin E; Ijoma CK; Onodugo OD; Okoye JU; Arodiwe EB; Ifebunandu NA; Chukwuka CJ; Onyedum CC; Ijoma UN; Nna E; Onuigbo M; Rosset S; Skorecki K
    Nephron Clin Pract; 2013; 123(1-2):123-8. PubMed ID: 23860441
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Genomics in the renal clinic - translating nephrogenetics for clinical practice.
    Mallett A; Corney C; McCarthy H; Alexander SI; Healy H
    Hum Genomics; 2015 Jun; 9(1):13. PubMed ID: 26104748
    [TBL] [Abstract][Full Text] [Related]  

  • 10. APOL1: a case in point for replacing race with genetics.
    Nadkarni GN; Wyatt CM; Murphy B; Ross MJ
    Kidney Int; 2017 Apr; 91(4):768-770. PubMed ID: 28314574
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Community-based CKD study in Japan].
    Fujii N
    Nihon Jinzo Gakkai Shi; 2015; 57(8):1281-9. PubMed ID: 26817153
    [No Abstract]   [Full Text] [Related]  

  • 12. How can genetics and epigenetics help the nephrologist improve the diagnosis and treatment of chronic kidney disease patients?
    Witasp A; Ekström TJ; Schalling M; Lindholm B; Stenvinkel P; Nordfors L
    Nephrol Dial Transplant; 2014 May; 29(5):972-80. PubMed ID: 24569498
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The genetics of common kidney disease: a pathway toward clinical relevance.
    Drawz PE; Sedor JR
    Nat Rev Nephrol; 2011 Jun; 7(8):458-68. PubMed ID: 21712849
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Translational science in chronic kidney disease.
    Sanchez-Niño MD; Sanz AB; Ramos AM; Ruiz-Ortega M; Ortiz A
    Clin Sci (Lond); 2017 Jul; 131(14):1617-1629. PubMed ID: 28667063
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Renin-angiotensin-aldosterone system related gene polymorphisms and urinary total arsenic is related to chronic kidney disease.
    Chen WJ; Huang YL; Shiue HS; Chen TW; Lin YF; Huang CY; Lin YC; Han BC; Hsueh YM
    Toxicol Appl Pharmacol; 2014 Sep; 279(2):95-102. PubMed ID: 24907556
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Apolipoprotein L1 and apolipoprotein A-IV and their association with kidney function.
    Kronenberg F
    Curr Opin Lipidol; 2017 Feb; 28(1):39-45. PubMed ID: 27870653
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Integrated genomics and metabolomics in nephrology.
    Atzler D; Schwedhelm E; Zeller T
    Nephrol Dial Transplant; 2014 Aug; 29(8):1467-74. PubMed ID: 24366899
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Plasma Levels of Risk-Variant APOL1 Do Not Associate with Renal Disease in a Population-Based Cohort.
    Kozlitina J; Zhou H; Brown PN; Rohm RJ; Pan Y; Ayanoglu G; Du X; Rimmer E; Reilly DF; Roddy TP; Cully DF; Vogt TF; Blom D; Hoek M
    J Am Soc Nephrol; 2016 Oct; 27(10):3204-3219. PubMed ID: 27005919
    [TBL] [Abstract][Full Text] [Related]  

  • 19. APOL1 polymorphisms and development of CKD in an identical twin donor and recipient pair.
    Kofman T; Audard V; Narjoz C; Gribouval O; Matignon M; Leibler C; Desvaux D; Lang P; Grimbert P
    Am J Kidney Dis; 2014 May; 63(5):816-9. PubMed ID: 24518129
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A Custom Targeted Next-Generation Sequencing Gene Panel for the Diagnosis of Genetic Nephropathies.
    Larsen CP; Durfee T; Wilson JD; Beggs ML
    Am J Kidney Dis; 2016 Jun; 67(6):992-3. PubMed ID: 26795916
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.